World ReportEbola vaccine trial in west Africa faces criticism
Section snippets
NIH trial
On May 13, at a Paris meeting that Grais calls “the big pow-wow”, those groups will meet with Clifford Lane, deputy director of the US National Institutes of Health's Institute of Allergy and Infectious Diseases, who is expected to propose a third vaccine trial for Guinea: a randomised controlled trial that has already started in Liberia, pitting the Merck vaccine against the GlaxoSmithKline cAd3-EBOZ vaccine.
WHO Assistant Director General Marie-Paule Kieny opposes the expansion of the NIH
Protecting participants
But battling a high-profile US science project is only one of several issues that the WHO trial faces. It is receiving criticism from anthropologists and others in Guinea for how it protects volunteers who are vaccinated and develop fever, a known side-effect of the Merck vaccine, and for its reliance on an Ebola treatment centre that might not be able to provide the level of care required for clinical trial participants.
The rVSV-EBOV vaccine was proven safe in human safety trials at multiple
Concern over Coyah
Vinh-Kim Nguyen, a medical anthropologist at Université de Montréal, has been working in Guinea and raised further questions about safety in the ring trial after spending time in April at one of the Ebola treatment units where trial participants are taken if they become ill, the centre in Coyah, about 50 km from the capital of Conakry. Unlike most Ebola treatment units, which are run by MSF, the Red Cross, and other international agencies, the Guinean Government runs the Coyah unit, with
References (0)
Cited by (8)
Ethical Considerations in Vaccine Trials in Resource-Limited Settings
2016, The Vaccine Book: Second EditionEbola vaccine trial in Guinea
2015, The LancetComputational Models for Trapping Ebola Virus Using Engineered Bacteria
2018, IEEE/ACM Transactions on Computational Biology and BioinformaticsGlobal Bioheroes: clinical research and new vaccines for health security
2018, Australian Journal of International AffairsResearch priorities during infectious disease emergencies in West Africa
2018, BMC Research NotesGood collaborative practice: Reforming capacity building governance of international health research partnerships
2018, Globalization and Health